Toviaz
Toviaz is a medicine authorised by Swissmedic under authorisation number 58743. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 December 2008 and the authorisation is valid without a time limit. ATC code G04BD11 places the medicine in the group Urologicals.
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Toviaz, Retardtabletten 4 mg | B | 18 December 2008 |
| 2 | Toviaz, Retardtabletten 8 mg | B | 18 December 2008 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 14 | Tablette(n) | G04BD11 | 05.02.0. | B |
| 3 | 84 | Tablette(n) | G04BD11 | 05.02.0. | B |
| 4 | 14 | Tablette(n) | G04BD11 | 05.02.0. | B |
| 6 | 84 | Tablette(n) | G04BD11 | 05.02.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Toviaz authorised in Switzerland?
Yes. Toviaz is authorised by Swissmedic under authorisation number 58743, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Toviaz have?
Toviaz is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Toviaz?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.